Cargando…
Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana
BACKGROUND: Anti-malarial drug resistance remains a key concern for the global fight against malaria. In Ghana sulfadoxine-pyrimethamine (SP) is used for intermittent preventive treatment of malaria in pregnancy and combined with amodiaquine for Seasonal Malaria Chemoprevention (SMC) during the high...
Autores principales: | Amenga-Etego, Lucas N., Asoala, Victor, Agongo, Godfred, Jacob, Christopher, Goncalves, Sonia, Awandare, Gordon A., Rockett, Kirk A., Kwiatkowski, Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968364/ https://www.ncbi.nlm.nih.gov/pubmed/33731134 http://dx.doi.org/10.1186/s12936-021-03693-3 |
Ejemplares similares
-
Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana
por: Anto, Francis, et al.
Publicado: (2019) -
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
por: Ravenhall, Matt, et al.
Publicado: (2016) -
Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016) -
Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2022) -
Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
por: Elamin, Sakina B, et al.
Publicado: (2005)